Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody

Ana María Hernández, Darién Toledo, Darel Martínez, Tania Griñán, Victor Brito, Amparo Macías, Sailyn Alfonso, Teresa Rondón, Eduardo Suárez, Ana María Vázquez, Rolando Pérez

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

72 Citas (Scopus)

Resumen

1E10 mAb is an anti-Id murine mAb (Ab2 mAb) specific for an Ab1 mAb that reacts with NeuGc-containing gangliosides, sulfatides, and Ags expressed in some human tumors. In preclinical studies, this Ab2 Ab was able to mimic NeuGc-containing gangliosides only in animals lacking expression of these Ags in normal tissues. In this study, we report on the immune responses elicited in 20 non-small cell lung cancer patients treated with 1 mg of aluminum hydroxide-precipitated 1E10 mAb. In the hyperimmune sera from 16 of 20 patients, a strong specific Ab response of both IgM and IgG isotypes against NeuGcGM3 ganglioside was observed. Patient immune sera were able to induce complement-independent cell death of NeuGcGM3-expressing X63 murine myeloma target cells. Significant immunoreactivity to NeuGcGM3 was still detected after the complete abrogation of the reactivity against 1E10 mAb by the adsorption of patient sera with this Ab. We hypothesize that Id-Ag+ Abs could reflect the activation of an autologous idiotypic cascade into the patients. Both Id+Ag+ and Id-Ag+ fractions were separated by affinity chromatography and characterized. Although IgG isotype Abs were found in both fractions, IgM isotype Abs were found only in the Id-Ag+ fraction. Both Id+Ag+ and Id-Ag+ Abs were able to specifically recognize and induce cell death in NeuGcGM3-expressing X63 myeloma target cells. Patients that developed IgG and/or IgM Abs against NeuGcGM3 showed longer median survival times.

Idioma originalInglés
Páginas (desde-hasta)6625-6634
Número de páginas10
PublicaciónJournal of Immunology
Volumen181
N.º9
DOI
EstadoPublicada - 1 nov. 2008
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody'. En conjunto forman una huella única.

Citar esto